Postpartum Cortical Vein Thrombosis With Hemorrhagic Infarction
A 29-year-old woman, 10 days postpartum, has had a worsening bifrontal headache for 5 days, worse lying flat and with coughing. She is breastfeeding and used combined oral contraceptives before pregnancy. Today she had a single generalized tonic-clonic seizure. She is drowsy but follows commands, has mild right pronator drift, and has bilateral papilledema. Noncontrast CT shows a 3 cm right frontal hemorrhagic venous infarct with surrounding edema and no midline shift; CT venography shows thrombosis of the superior sagittal sinus, both cortical veins, and the right transverse sinus. Blood pressure is 118/70 mm Hg, platelets 240,000, and INR 1.0. The admitting team is reluctant to anticoagulate a patient with a brain hemorrhage and asks about seizure medication, thrombophilia testing, and whether she needs a decompressive craniectomy today.
1. Address the anticoagulation question directly: why would you give a therapeutic anticoagulant to a patient who already has a hemorrhage, and how do you choose and monitor it?
Read the worked answer
Because this is a venous problem, and the hemorrhage is a consequence of the occlusion, not a reason to withhold treatment. Cortical vein and sinus thrombosis raises venular and capillary pressure until the venous infarct becomes hemorrhagic. The hemorrhage is under high venous pressure, and the only way to lower that pressure is to restore or limit obstruction to outflow. Heparin limits thrombus propagation, prevents involvement of additional sinus segments and the deep venous system, and improves outcome. The risk of clinically significant worsening of the hemorrhage after anticoagulation is low in reported series - lower than the risk of untreated progression.
Practical approach: start therapeutic low-molecular-weight heparin (for example, enoxaparin 1 mg/kg twice daily) or dose-adjusted intravenous unfractionated heparin. Guidelines endorse either, even with a hemorrhagic infarct; unfractionated heparin is easier to stop if she deteriorates or needs a procedure. Do not wait for repeat imaging to show that the hemorrhage is stable, and do not give antiplatelet therapy instead.
Monitoring: her renal function is presumably normal, so low-molecular-weight heparin is convenient; check a baseline anti-Xa level if there is concern about accumulation (obesity or renal impairment) and platelet counts for heparin-induced thrombocytopenia. Do not target an INR in the acute phase; oral anticoagulation is transitioned later, and in a breastfeeding patient warfarin or low-molecular-weight heparin is preferred over a direct oral anticoagulant.
2. How do you manage the seizure, the papilledema, and the question of thrombophilia testing and contraceptive counseling?
Read the worked answer
Seizure: she had a provoked seizure from the hemorrhagic cortical lesion, so treat - levetiracetam is a reasonable first choice with no hepatic interaction and compatibility with breastfeeding. This is treatment of an event, not prophylaxis: routine prophylactic antiepileptic drugs are not recommended for all patients with cortical venous thrombosis and no seizure, though many clinicians treat lesions with supratentorial hemorrhage. Plan to reassess after the acute phase; if she remains seizure-free on imaging-guided follow-up, tapering after roughly 3–6 months can be considered with appropriate driving advice and jurisdiction-specific restrictions.
Papilledema: monitor visual acuity and fields; the main threat is progressive visual loss from raised intracranial pressure. Serial fundoscopy plus acetazolamide is reasonable, with ophthalmology involvement. A lumbar puncture is generally avoided in the acute phase with a large hemorrhagic infarct, but if vision deteriorates despite medical therapy, a shunt or optic nerve sheath fenestration can be considered.
Thrombophilia testing: do not order protein C, protein S, antithrombin, or factor VIII levels now - pregnancy, the postpartum state, and the acute thrombosis itself all distort them. Antiphospholipid antibodies should be checked but must be repeated at least 12 weeks apart to be meaningful. Pregnancy and the puerperium are transient risk factors, so testing is unlikely to change acute management.
Counseling: she must avoid combined estrogen-containing contraceptives permanently and be offered progestin-only or nonhormonal methods. Future pregnancies warrant prophylactic low-molecular-weight heparin and prepregnancy planning.
3. What would prompt escalation to endovascular treatment or surgery, and is craniectomy indicated today? How long should she be anticoagulated?
Read the worked answer
Not today. She has no midline shift, follows commands, and has only mild focal deficit. Decompressive craniectomy is reserved for patients with, or imminently approaching, transtentorial herniation from a large venous infarct; it is a rescue therapy and is often remarkably effective in this population because venous infarcts are less often irreversibly necrotic than arterial ones. Similarly, endovascular thrombectomy or intrasinus thrombolysis for cerebral venous thrombosis is a rescue option for patients who deteriorate neurologically despite adequate anticoagulation, not a first-line treatment.
Triggers to escalate: declining consciousness, new pupillary asymmetry or posturing, worsening imaging with expansion or new venous infarction, or progressive visual loss. In that setting, obtain urgent imaging, confirm that anticoagulation is adequate, involve neurosurgery and neurointervention, and consider repeat imaging to distinguish hemorrhagic expansion from edema.
Duration: postpartum state and estrogen exposure are transient provoking factors, so a defined course of roughly 3–6 months of therapeutic anticoagulation is standard, followed by clinical reassessment. If a persistent thrombophilia, a myeloproliferative disorder, or recurrent thrombosis emerges, indefinite anticoagulation is warranted. At the end of the course, repeat venous imaging to document recanalization, and involve hematology if there is any question about duration.